Janku C, Engel P, Patel K, Giraldo E
Cureus. 2023; 15(9):e45382.
PMID: 37854727
PMC: 10579623.
DOI: 10.7759/cureus.45382.
You C, Zeng W, Deng L, Lei Z, Gao X, Zhang V
Front Neurol. 2020; 11:319.
PMID: 32431660
PMC: 7214681.
DOI: 10.3389/fneur.2020.00319.
Klec C, Ziomek G, Pichler M, Malli R, Graier W
Int J Mol Sci. 2019; 20(24).
PMID: 31817135
PMC: 6940736.
DOI: 10.3390/ijms20246110.
Wu S, Song W, Wong C, Shi Y
Proc Natl Acad Sci U S A. 2018; 116(1):141-147.
PMID: 30559186
PMC: 6320538.
DOI: 10.1073/pnas.1810870116.
Ramos E, Koros C, Dokuru D, Van Berlo V, Kroupis C, Wojta K
Neurobiol Aging. 2018; 75:224.e1-224.e8.
PMID: 30528349
PMC: 6553875.
DOI: 10.1016/j.neurobiolaging.2018.10.029.
Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase.
Sun L, Zhou R, Yang G, Shi Y
Proc Natl Acad Sci U S A. 2016; 114(4):E476-E485.
PMID: 27930341
PMC: 5278480.
DOI: 10.1073/pnas.1618657114.
Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.
Wood E, Falcone D, Suh E, Irwin D, Chen-Plotkin A, Lee E
JAMA Neurol. 2013; 70(11):1411-7.
PMID: 24081456
PMC: 3906581.
DOI: 10.1001/jamaneurol.2013.3956.
Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.
Kitazawa M, Medeiros R, LaFerla F
Curr Pharm Des. 2012; 18(8):1131-47.
PMID: 22288400
PMC: 4437619.
DOI: 10.2174/138161212799315786.
Correlating familial Alzheimer's disease gene mutations with clinical phenotype.
Ryan N, Rossor M
Biomark Med. 2010; 4(1):99-112.
PMID: 20387306
PMC: 3937872.
DOI: 10.2217/bmm.09.92.
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.
Bruni A, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F
Neurology. 2010; 74(10):798-806.
PMID: 20164095
PMC: 3672006.
DOI: 10.1212/WNL.0b013e3181d52785.
Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia.
Gallo M, Tomaino C, Puccio G, Frangipane F, Curcio S, Bernardi L
Neurol Sci. 2009; 31(1):65-70.
PMID: 19768372
DOI: 10.1007/s10072-009-0132-9.
APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.
Bookheimer S, Burggren A
Annu Rev Clin Psychol. 2009; 5:343-62.
PMID: 19327032
PMC: 3118550.
DOI: 10.1146/annurev.clinpsy.032408.153625.
Clinical picture of a patient with a novel PSEN1 mutation (L424V).
Robles A, Sobrido M, Garcia-Murias M, Prieto J, Lema M, Santos D
Am J Alzheimers Dis Other Demen. 2008; 24(1):40-5.
PMID: 19001354
PMC: 10846114.
DOI: 10.1177/1533317508324272.
Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
Tosto G, Talarico G, Lenzi G, Bruno G
Neurol Sci. 2008; 29(4):269-70.
PMID: 18810603
DOI: 10.1007/s10072-008-0979-1.
Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.
Nelson O, Tu H, Lei T, Bentahir M, De Strooper B, Bezprozvanny I
J Clin Invest. 2007; 117(5):1230-9.
PMID: 17431506
PMC: 1847535.
DOI: 10.1172/JCI30447.
Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.
Pijnenburg Y, Schoonenboom S, Mehta P, Mehta S, Mulder C, Veerhuis R
J Neurol Neurosurg Psychiatry. 2007; 78(7):735-7.
PMID: 17371907
PMC: 2117666.
DOI: 10.1136/jnnp.2006.105064.
Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations.
Mendez M, McMurtray A
Am J Alzheimers Dis Other Demen. 2006; 21(4):281-6.
PMID: 16948293
PMC: 10833339.
DOI: 10.1177/1533317506290448.
Pathological and physiological functions of presenilins.
Vetrivel K, Zhang Y, Xu H, Thinakaran G
Mol Neurodegener. 2006; 1:4.
PMID: 16930451
PMC: 1513131.
DOI: 10.1186/1750-1326-1-4.
Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.
Larner A, Doran M
J Neurol. 2005; 253(2):139-58.
PMID: 16267640
DOI: 10.1007/s00415-005-0019-5.